Banco Bilbao Vizcaya Argentaria, S.A. Nu Cana PLC Transaction History

Banco Bilbao Vizcaya Argentaria, S.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$4.57 - $6.48 $594,100 - $842,400	-130,000 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$4.87 - $7.37 $389,600 - $589,600	80,000 Added 160.0%	130,000 $703,000
Q1 2020 May 13, 2020	BUY	$4.02 - $9.05 $200,999 - $452,500	50,000 New	50,000 $280,000

3.33M

Ticker NCNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,196,000
Market Cap $59M
Description
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...

Get notified when there are updates to the investment portfolio of Banco Bilbao Vizcaya Argentaria, S.A., based on Form 13F filings with the SEC.

Stay updated on Banco Bilbao Vizcaya Argentaria, S.A. with notifications on news.